Inmune Bio, Inc.
Develops immunotherapies reprogramming innate immunity for cancer, Alzheimer's, and inflammation.
INMB | NDAQ
Overview
Corporate Details
- ISIN(s):
- US45782T1051
- LEI:
- Country:
- United States of America
- Address:
- 225 NE MIZNER BLVD, SUITE 640, 33432 BOCA RATON
- Website:
- https://www.inmunebio.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Inmune Bio, Inc. is a clinical-stage biotechnology company focused on developing immunotherapies that reprogram the patient's innate immune system to combat diseases. The company's therapeutic focus includes cancer (immuno-oncology), Alzheimer's disease, and other conditions driven by chronic inflammation. Utilizing a precision medicine approach, Inmune Bio matches its drug's mechanism of action to the patient's underlying biology. Its product platforms are designed to treat a wide variety of hematologic and solid tumors, with a clinical development strategy that prioritizes patient-centric outcomes and progressive trial designs.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Inmune Bio, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Inmune Bio, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Inmune Bio, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
